Your browser doesn't support javascript.
loading
Low baseline vitamin D levels increase the risk of bone metastases among females with breast cancer - Hospital based cohort study.
Mohamed, Rehab F; Barakat, Dina B S; Eid, Samir; Kamal, Dalia T; Elnaggar, Maha S.
Afiliação
  • Mohamed RF; Clinical Oncology Department, Faculty of Medicine, Assiut University, Assiut, Egypt. Electronic address: foroukrehab@aun.edu.eg.
  • Barakat DBS; Clinical Oncology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Eid S; Clinical Oncology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Kamal DT; Clinical Pathology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Elnaggar MS; Clinical Oncology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Cancer Epidemiol ; 85: 102374, 2023 08.
Article em En | MEDLINE | ID: mdl-37148827
ABSTRACT

BACKGROUND:

Serum vitamin D (Vit-D) has been linked to the development of breast cancer (BC); however, their effect on pathological features and outcomes is undetermined. The purpose of this study was to examine the prognostic significance of baseline Vit-D levels and their effect on clinical outcomes.

METHODS:

We evaluated baseline serum Vit-D levels and baseline clinic-pathological features of female patients with non-metastatic BC between October 2018 and December 2019. A low Vit-D level was described as less than 30 nanogram per liter (ng/l). Patients were observed for a median of 24 months. To evaluate relationships between qualitative variables, the chi-square test was used. The Kaplan-Meier technique was used for survival analysis, and the log-rank test was used to compare the two survival curves. Correlation analysis was also used to examine the link between Vit-D levels and clinical outcomes.

RESULTS:

The eligibility criteria were fulfilled by 221 patients. The median age of onset was (50.7). The median Vit-D level was (23.1 ng/l) with a range of (4-46 ng/l). Approximately half of the patients (56.5%) had Vit-D levels < 30 ng/l, with HER2 positive and triple negative (TNBC) patients having a greater proportion of low Vit-D levels (p = <0.001). Patients with low baseline Vit-D levels had a larger tumor size, more positive lymph nodes, and were diagnosed at a later stage. Following follow-up, Vit-D deficiency was associated with a significantly increased risk of bone metastases (HR 3.37, 95% CI 1.32-8.59, p = 0.006), and Vit-D levels were significantly correlated with disease-free survival (DFS) and overall survival (OS) (r = 0.850, r = 0.573, p < 0.00, p < 0.001, respectively).

CONCLUSIONS:

Low serum Vit-D is associated with advanced stage and adverse characteristics. It is more prevalent in HER-2 positive and TNBC patients; it increases the chance of bone metastases, and has a significant correlation with DFS and OS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Deficiência de Vitamina D / Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Cancer Epidemiol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Deficiência de Vitamina D / Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Cancer Epidemiol Ano de publicação: 2023 Tipo de documento: Article